These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of Optical Coherence Tomography in optic neuropathies. Iorga RE; Moraru A; Ozturk MR; Costin D Rom J Ophthalmol; 2018; 62(1):3-14. PubMed ID: 29796429 [TBL] [Abstract][Full Text] [Related]
4. Optical coherence tomography: a window to the optic nerve in clinically isolated syndrome. London F; Zéphir H; Drumez E; Labreuche J; Hadhoum N; Lannoy J; Hodel J; Vermersch P; Pruvo JP; Leclerc X; Outteryck O Brain; 2019 Apr; 142(4):903-915. PubMed ID: 30847470 [TBL] [Abstract][Full Text] [Related]
5. Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study. Nolan-Kenney RC; Liu M; Akhand O; Calabresi PA; Paul F; Petzold A; Balk L; Brandt AU; Martínez-Lapiscina EH; Saidha S; Villoslada P; Al-Hassan AA; Behbehani R; Frohman EM; Frohman T; Havla J; Hemmer B; Jiang H; Knier B; Korn T; Leocani L; Papadopoulou A; Pisa M; Zimmermann H; Galetta SL; Balcer LJ; Ann Neurol; 2019 May; 85(5):618-629. PubMed ID: 30851125 [TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and differential diagnosis of demyelinating optic neuropathy in multiple sclerosis]. Bisaga GN; Kovalenko AV; Kovalenko IIu Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9 Pt 2):10-22. PubMed ID: 23235421 [TBL] [Abstract][Full Text] [Related]
7. Optic neuritis in relation to demyelinating diseases; a clinical study. SCHLOSSMAN A; PHILLIPS CC Am J Ophthalmol; 1954 Apr; 37(4):487-94. PubMed ID: 13148276 [No Abstract] [Full Text] [Related]
8. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Saidha S; Syc SB; Ibrahim MA; Eckstein C; Warner CV; Farrell SK; Oakley JD; Durbin MK; Meyer SA; Balcer LJ; Frohman EM; Rosenzweig JM; Newsome SD; Ratchford JN; Nguyen QD; Calabresi PA Brain; 2011 Feb; 134(Pt 2):518-33. PubMed ID: 21252110 [TBL] [Abstract][Full Text] [Related]
16. Optical Coherence Tomography in the Management of Skull Base Fibrous Dysplasia with Optic Nerve Involvement. Loewenstern J; Hernandez CM; Chadwick C; Doshi A; Banik R; Sarkiss CA; Bederson J; Shrivastava RK World Neurosurg; 2018 Jan; 109():e546-e553. PubMed ID: 29038079 [TBL] [Abstract][Full Text] [Related]
17. The optic nerve should be included as one of the typical CNS regions for establishing dissemination in space when diagnosing MS - Yes. Galetta SL; Balcer LJ Mult Scler; 2018 Feb; 24(2):121-122. PubMed ID: 29059003 [No Abstract] [Full Text] [Related]
18. Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis. Gordon-Lipkin E; Calabresi PA J Neuroimmunol; 2017 Mar; 304():93-96. PubMed ID: 28038893 [TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomography: another useful tool in a neuro-ophthalmologist's armamentarium. Subei AM; Eggenberger ER Curr Opin Ophthalmol; 2009 Nov; 20(6):462-6. PubMed ID: 19696668 [TBL] [Abstract][Full Text] [Related]
20. Optical Coherence Tomography: A Potential Noninvasive Follow-up Tool in Multiple Sclerosis. Agrawal R Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2318. PubMed ID: 27127931 [No Abstract] [Full Text] [Related] [Next] [New Search]